Journal
CLINICS IN PERINATOLOGY
Volume 37, Issue 4, Pages 873-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.clp.2010.08.002
Keywords
HIV-1; Perinatal transmission; Infants; Children
Categories
Funding
- Bristol-Myers Squibb
- Cubist Pharmaceuticals
- GlaxoSmithKline
- Emory Center for AIDS Research [P30 AI050409]
Ask authors/readers for more resources
Despite well-established strategies to decrease the mother-to-child transmission of HIV-1, new perinatal infections continue to occur globally, reflecting marked disparities in access to health care. Once HIV-1-infection has been established in an infant, the combination of early initiation of antiretroviral therapy and prophylaxis against Pneumocystis jiroveci pneumonia is paramount to reducing disease progression. This article reviews the recommendations and evidence for the treatment of HIV-1-infected infants.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available